MedTrace Logo

Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease

NCT00979199 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 697

Last updated 2014-07-21

Study results available
· View outcomes & findings →

Summary

Main purpose of the study:

To comparatively assess the diagnostic performance of non invasive anatomical and functional imaging modalities to detect significant obstructive coronary artery disease as demonstrated at invasive coronary angiography and functional evaluation of coronary lesions (fractional flow reserve).

Conditions

  • Ischemic Heart Disease

Interventions

OTHER

Non invasive cardiac imaging

Non invasive cardiac imaging consists of CTCA combined with one Stress Imaging Test

Sponsors & Collaborators

  • European Commission

    collaborator OTHER

  • Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

    lead OTHER_GOV

Principal Investigators

  • Danilo Neglia, MD, PhD · Fondazione Toscana G. Monasterio, Pisa, Italy

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-07-31
Completion
2012-06-30

Countries

  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00979199 on ClinicalTrials.gov